Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5

Patent No. EP2978451 (titled "Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5") was filed by Alexion Pharmaceuticals on Mar 28, 2014. The application was issued on Nov 27, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALNYLAM PHARMACEUTICALSAug 27, 2020HOFFMANN EITLE
REGENERON PHARMACEUTICALSAug 27, 2020CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2978451

ALEXION PHARMACEUTICALS
Application Number
EP14722916A
Filing Date
Mar 28, 2014
Status
Revoked
May 5, 2023
Publication Date
Nov 27, 2019